Product information

Current status:

Cancelled Post Market

Current status date:

1999-08-04

Original market date: ^{See footnote 1}

1994-12-31

Product name:

LENTARON

DIN:

02128209 Electronic product monograph is not available

Company:

NOVARTIS PHARMACEUTICALS CANADA INC
100 700 Rue Saint-Hubert
Montreal
Quebec
Canada H2Y 0C1

Class:

Human

Dosage form(s):

Liquid ,  Powder For Solution

Route(s) of administration:

Intramuscular

Number of active ingredient(s):

2

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

10:00.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

L02BG02 FORMESTANE

Active ingredient group (AIG) number:^{See footnote5}

0226698001